Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2401
Q2 Holdings
QTWO
$4.58B
| $2.71M | ﹤0.01% |
48,872
-726
| -1% | -$43K |
2016 Q2
41 quarters
|
|
2402
Balchem Corp
BCPC
$5.52B
| $2.7M | ﹤0.01% |
16,385
+11,375
| +227% | +$1.94M |
2016 Q3
40 quarters
|
|
2403
Pony AI Inc
PONY
$2.05B
| $2.68M | ﹤0.01% |
410,308
+23,306
| +6% | +$170K |
2025 Q2
5 quarters
|
|
2404
Tutor Perini Cor
TPC
$5.33B
| $2.68M | ﹤0.01% |
32,467
+2,013
| +7% | +$173K |
2013 Q2
53 quarters
|
|
2405
Hycroft Mining Holding Corp
HYMC
$1.74B
| $2.68M | ﹤0.01% |
140,665
+50,750
| +56% | +$1.14M |
2025 Q3
4 quarters
|
|
2406
Lineage Inc
LINE
$8.06B
| $2.68M | ﹤0.01% |
78,474
-152,512
| -66% | -$6.2M |
2024 Q3
8 quarters
|
|
2407
Legence Corp
LGN
$2.85B
| $2.68M | ﹤0.01% |
49,873
-307,100
| -86% | -$19M |
2025 Q3
4 quarters
|
|
2408
Stock Yards Bancorp
SYBT
$2.47B
| $2.68M | ﹤0.01% |
34,727
+22,652
| +188% | +$1.83M |
2016 Q1
42 quarters
|
|
2409
Braze
BRZE
$5.28B
| $2.68M | ﹤0.01% |
106,596
+88,406
| +486% | +$2.37M |
2023 Q1
14 quarters
|
|
2410
Immunovant
IMVT
$7.67B
| $2.66M | ﹤0.01% |
78,688
+39,217
| +99% | +$1.55M |
2023 Q4
11 quarters
|
|
2411
Upbound Group
UPBD
$1.47B
| $2.65M | ﹤0.01% |
169,075
+114,025
| +207% | +$2.2M |
2013 Q2
53 quarters
|
|
2412
IDT Corp
IDT
$2.06B
| $2.65M | ﹤0.01% |
33,137
-23,946
| -42% | -$1.59M |
2016 Q2
41 quarters
|
|
2413
Amneal Pharmaceuticals
AMRX
$7.56B
| $2.65M | ﹤0.01% |
131,485
+21,122
| +19% | +$381K |
2018 Q2
33 quarters
|
|
2414
Innodata
INOD
$1.31B
| $2.64M | ﹤0.01% |
40,148
-505
| -1% | -$31.3K |
2023 Q1
14 quarters
|
|
2415
Altimmune
ALT
$375M
| $2.64M | ﹤0.01% |
922,127
+570,540
| +162% | +$1.75M |
2020 Q2
25 quarters
|
|
2416
PUT
Cheniere Energy
LNG
$62.2B
| $2.64M | ﹤0.01% |
+9,800
| New | +$2.63M |
2026 Q3
0 quarters
|
|
2417
Peabody Energy
BTU
$2.06B
| $2.63M | ﹤0.01% |
108,015
+14,037
| +15% | +$353K |
2017 Q2
37 quarters
|
|
2418
Lindblad Expeditions
LIND
$2.29B
| $2.63M | ﹤0.01% |
83,785
-87,605
| -51% | -$2.53M |
2015 Q2
45 quarters
|
|
2419
Strive Inc
ASST
$2.95B
| $2.62M | ﹤0.01% |
89,161
+19,739
| +28% | +$366K |
2026 Q1
2 quarters
|
|
2420
Enact Holdings
ACT
$6.21B
| $2.62M | ﹤0.01% |
60,542
+11,109
| +22% | +$531K |
2022 Q1
18 quarters
|
|
2421
National CineMedia
NCMI
$175M
| $2.61M | ﹤0.01% |
1,167,052
-842,972
| -42% | -$2.63M |
2023 Q4
11 quarters
|
|
2422
Capricor Therapeutics
CAPR
$652M
| $2.61M | ﹤0.01% |
275,957
+208,517
| +309% | +$2.31M |
2024 Q2
9 quarters
|
|
2423
Sunrun
RUN
$2.19B
| $2.61M | ﹤0.01% |
336,153
+280,495
| +504% | +$2.77M |
2015 Q3
44 quarters
|
|
2424
ADT
ADT
$7.25B
| $2.58M | ﹤0.01% |
423,967
+157,709
| +59% | +$1.12M |
2018 Q1
34 quarters
|
|
2425
Healthcare Services Group
HCSG
$1.7B
| $2.57M | ﹤0.01% |
125,881
+4,815
| +4% | +$109K |
2016 Q1
42 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.